Upstream Bio, Inc. (UPB) › Cash & EquivalentsUpstream Bio, Inc. (UPB) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $25.83M2024: $325.89M2025: $101.58M$101.58M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$101.58M-68.8%2024$325.89M+1161.5%2023$25.83M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share